Koers | 4.18 | Hoogste koers | 6.84 |
Laagste koers | 3.54 | 1-jrs rend. | 0.00 |
Gem. Koersd. | 13.30 | Ver. Rend. | 218.18 % |
Sector | Gezondheid | Subsector | Gezondheidsprodukten / diensten |
Verkopen | 0 | Rating |
![]() ![]() ![]() ![]() ![]() |
Houden | 0 | Consensus |
![]() |
Kopen | 2 |
Jaar | Omzet | Totaal omzet sector | Marktaandeel |
---|---|---|---|
2019 | 0 | 1,913,914 | 0.00 % |
2020 | 0 | 1,909,606 | 0.00 % |
2021 | 0 | 2,240,566 | 0.00 % |
2022 | 0 | 2,630,563 | 0.00 % |
2023 | 0 | 2,750,507 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
22 mei 2025 | KBC Securities | ONWARD | Kopen | 10.40 | 59.81 % |
22 december 2024 | DeGroof Petercam | ONWARD | Kopen | 16.20 | 74.20 % |
22 december 2024 | KBC Securities | ONWARD | Kopen | 10.40 | 59.81 % |
29 oktober 2024 | KBC Securities | ONWARD | Kopen | 9.10 | 54.07 % |
3 september 2024 | KBC Securities | ONWARD | Kopen | 9.30 | 55.05 % |
8 april 2024 | Stifel | ONWARD | Kopen | 12.00 | 64.58 % |
22 maart 2024 | KBC Securities | ONWARD | Kopen | 9.30 | 47.53 % |
11 maart 2024 | DeGroof Petercam | ONWARD | Kopen | 14.10 | 61.56 % |
9 februari 2024 | KBC Securities | ONWARD | Kopen | 10.00 | 38.40 % |
28 maart 2023 | DeGroof Petercam | ONWARD | Kopen | 14.10 | 66.60 % |
8 november 2022 | DeGroof Petercam | ONWARD | Kopen | 14.10 | 77.52 % |
13 september 2022 | DeGroof Petercam | ONWARD | Kopen | 14.50 | 70.90 % |
13 september 2022 | Kepler Capital Markets | ONWARD | Kopen | 14.00 | 69.86 % |
26 april 2022 | DeGroof Petercam | ONWARD | Kopen | 14.50 | 66.62 % |
23 maart 2022 | DeGroof Petercam | ONWARD | Kopen | 14.90 | 70.47 % |
ONWARD® kondigt de start van de HemON NL klinische studie aan
Onward publiceert sterke onderzoeksresultaten Up-LIFT studie
Bryan Garnier geeft aandelen ONWARD Medical een koopadvies en richtprijs van 17 euro
No Records Found
No Records Found
Resultaten |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Omzet |
0
|
0
|
0
|
0
|
0
|
|
Kosten |
0
|
0
|
0
|
9
|
13
|
20
|
Nettowinst |
0
|
0
|
0
|
-9
|
-13
|
-20
|
Winstmarge |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
ROI |
0.0
|
0.0
|
0.0
|
90.00
|
92.86
|
62.50
|
Balans |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Eigen vermogen |
0
|
0
|
0
|
-10
|
-14
|
-32
|
Vreemd vermogen |
0
|
0
|
0
|
19
|
37
|
46
|
Totaal vermogen |
0
|
0
|
0
|
9
|
23
|
14
|
Solvabiliteit |
0.0
|
0.0
|
0.0
|
-111.11
|
-60.87
|
-228.57
|
Cash |
0
|
0
|
0
|
8
|
15
|
6
|
Kasstroom |
0
|
0
|
0
|
-7
|
-9
|
-12
|
Werknemers |
0
|
0
|
0
|
0
|
0
|
|
Omzet per werknemer |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Kasstroom / vreemd vermogen |
0.0
|
0.0
|
0.0
|
-0.37
|
-0.24
|
-0.26
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Koers |
0.0
|
0.0
|
0.0
|
0.0
|
4.18
|
Winst per aandeel |
0.0
|
0.0
|
0.0
|
0.0
|
|
Koers / winst-verhouding |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Boekwaarde |
0.0
|
0.0
|
-0.34
|
-0.47
|
-1.07
|
Boek / koers |
0.0
|
0.0
|
0.0
|
0.0
|
-0.26
|
Kasstroom per aandeel |
0.0
|
0.0
|
-0.23
|
-0.30
|
-0.40
|
Aandelen |
0
|
0
|
30
|
30
|
30
|
Marktkap. |
0,00
|
0,00
|
0,00
|
0,00
|
124,57
|
Datum
|
Koers
|
---|---|
23 jul
|
4.18
|
18 jul
|
4.32
|
17 jul
|
4.34
|
16 jul
|
4.41
|
15 jul
|
4.43
|
14 jul
|
4.45
|
11 jul
|
4.47
|
10 jul
|
4.54
|
09 jul
|
4.43
|
08 jul
|
4.49
|
07 jul
|
4.57
|
04 jul
|
4.58
|
03 jul
|
4.66
|
02 jul
|
4.62
|
01 jul
|
4.49
|
30 jun
|
4.35
|
27 jun
|
4.44
|
26 jun
|
4.47
|
25 jun
|
4.54
|
24 jun
|
4.45
|
23 jun
|
4.38
|
20 jun
|
4.37
|
19 jun
|
4.34
|
18 jun
|
4.42
|
17 jun
|
4.38
|
16 jun
|
4.20
|
13 jun
|
4.17
|
12 jun
|
4.17
|
11 jun
|
4.27
|
10 jun
|
4.39
|